Galectin Therapeutics (GALT) Net Equity Issued and Repurchased (2009 - 2026)
Galectin Therapeutics' Net Equity Issued and Repurchased came in at $1.16 million for Q4 2025, up 36.8% from $851,000 a year earlier and up 36.5% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For FY2025, Galectin Therapeutics' Net Equity Issued and Repurchased was $3.24 million, up 163.7% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 65.2% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $1.23 million in FY2024 (-87.8%), $10.03 million in FY2023 and $6.81 million in FY2021.
- The Q4 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | -347.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -347.25 Mn |
| Mar 31, 2026 | -173,333.00 |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | -561.00 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.48 |
| Dec 31, 2024 | 851,000.00 |
| Sep 30, 2024 | 1,980.00 |
| Jun 30, 2024 | 2,090.00 |
| Mar 31, 2024 | -42,083.00 |
| Sep 30, 2023 | 10.03 Mn |
| Jun 30, 2023 | -1,220.00 |
| Mar 31, 2023 | -1.23 |
| Dec 31, 2021 | -1,000.00 |
| Jun 30, 2021 | 6.82 Mn |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | 219,000.00 |
| Dec 31, 2019 | 902,000.00 |
| Sep 30, 2019 | 163,000.00 |
| Jun 30, 2019 | 47.40 Mn |
API Access
Galectin Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();